TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TXG

10X Genomics Inc

Healthcare · Health Information Services

79.10$ +3.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

10X Genomics Inc (TXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,041 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TXG
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
76 124 606 929 1,019 1,029 965 919 1,041
68 106 481 774 748 635 596 584 684
48 65 424 664 587 220 359 344 474
48 65 424 664 587 430 389 393 523
13 28 33 51 85 104 115 88 82
4.8 8.6 15 30 60 82 74 83 56
6.9 11 49 73 230 289
0.0 0.0 0.0 4.5 4.5 4.5 4.5 4.5
0.0 0.4 0.4 22 25 23 17 16 62
188 344 186 190 201 223 224 209 245
22 32 63 118 110 131 127 118 153
4.2 4.2 9.9 5.9 5.1 9.0 12 9.3 11
5.4 8.8 13 4.7 17 22 16 13 13
6.3 25 20
-113 -220 420 739 818 806 741 710 796
-119 -231 -262 -805 -863 -1,029 -1,284 -1,467 -1,511
12 13 78 101 110 114 117 120 125

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?